Tages Anzeiger features Don W. Cleveland’s work in article “The tamer of severe brain disorders”
The groundbreaking research of NOMIS Distinguished Scientist Awardee Don W. Cleveland is the subject of Swiss newspaper the Tages Anzeiger’s article “Der Bändiger von schweren Hirnleiden” (“The tamer of severe brain disorders”). Cleveland developed gene-silencing therapies, called designer DNA drugs, which he demonstrated can significantly slow the progression of ALS (amyotrophic lateral sclerosis) in mice. The designer DNA drugs are being tested in clinical trials to treat neurodegenerative diseases such as ALS, Huntington’s disease, Alzheimer’s or frontotemporal dementia.
NOMIS is supporting Cleveland’s research project, Mechanisms of Gene Silencing and Liquid-Liquid De-mixing in the Nervous System.
NOMIS researchers
About Don W. Cleveland Don W. Cleveland is a 2018 NOMIS Awardee and has been professor and department chair of Cellular and Molecular Medicine at the University of California San Diego (UC San Diego) since 2008. Cleveland grew up in Las Cruces, NM, US. He earned a BS in physics from New Mexico State University, […]
Professor and department chair of Cellular and Molecular Medicine
UC San Diego – School of Medicine
NOMIS Project(s)
Mechanisms of Gene Silencing and Liquid-Liquid De-mixing in the Nervous System
As the world’s population ages, the burden of neurodegenerative diseases on patients, families and society continues to escalate. Fortunately, breakthrough discoveries have identified the genetic causes underlying major human nervous system diseases and have transformed how we view these previously intractable disorders. A new era of molecular discovery is uncovering the mechanisms that go wrong […]
NOMIS researcher
Project period
2018 – 2023
